Literature DB >> 19451757

Structural differences within negative and depressive syndrome dimensions in schizophrenia, organic brain disease, and major depression: A confirmatory factor analysis of the positive and negative syndrome scale.

Daniel P Eisenberg1, Dmitry B Aniskin, Leonard White, Judith A Stein, Philip D Harvey, Igor I Galynker.   

Abstract

OBJECTIVE: The emerging dimensional approach to classification and treatment of psychiatric disorders calls for better understanding of diagnosis-related variations in psychiatric syndromes and for proper validation of psychometric scales used for the evaluation of those syndromes. This study tested the hypothesis that negative and depressive syndromes as measured by the Positive and Negative Syndrome Scale (PANSS) are consistent across different diagnoses.
METHOD: We administered the PANSS to subjects with schizophrenia (n = 305), organic brain disease (OBD, n = 66) and major depressive disorder (MDD, n = 75). Confirmatory factor analysis (CFA) was used to establish if the PANSS items for negative symptoms and for depression fit the hypothesized factor structure and if the item factor loadings were similar among the diagnostic groups.
RESULTS: The negative and depressive symptom subscales fit well according to a variety of fit indexes for all groups individually after some modest model modification. However, multisample modeling procedures indicated that the pattern of factor loadings was significantly different among the groups in most cases.
CONCLUSION: The results of this study indicate diagnosis-related variations in the negative and depressive syndrome dimensions in schizophrenia, OBD and MDD. These results also validate limited use of the PANSS for evaluation of negative and depressive syndromes in disorders other than schizophrenia. Larger studies are warranted to further evaluate clinical and nosologic significance of diagnostic categories, dimensions and structures of psychiatric syndromes. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19451757      PMCID: PMC2705906          DOI: 10.1159/000218522

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  34 in total

1.  Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders.

Authors:  D M Purnine; K B Carey; S A Maisto; M P Carey
Journal:  J Nerv Ment Dis       Date:  2000-10       Impact factor: 2.254

Review 2.  Negative symptoms: the 'pathology' of motivation and goal-directed behaviour.

Authors:  R G Brown; G Pluck
Journal:  Trends Neurosci       Date:  2000-09       Impact factor: 13.837

3.  A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.

Authors:  George S Zubenko; Wendy N Zubenko; Susan McPherson; Eleanor Spoor; Deborah B Marin; Martin R Farlow; Glenn E Smith; Yonas E Geda; Jeffrey L Cummings; Ronald C Petersen; Trey Sunderland
Journal:  Am J Psychiatry       Date:  2003-05       Impact factor: 18.112

4.  Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.

Authors:  D Aarsland; I Litvan; J P Larsen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

5.  Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.

Authors:  R A Emsley; P P Oosthuizen; A F Joubert; M C Roberts; D J Stein
Journal:  J Clin Psychiatry       Date:  1999-11       Impact factor: 4.384

6.  Dimensions of major psychoses: a confirmatory factor analysis of six competing models.

Authors:  Alessandro Serretti; Paolo Olgiati
Journal:  Psychiatry Res       Date:  2004-06-30       Impact factor: 3.222

7.  The negative syndrome as a dimension: factor analyses of PANSS in major depressive disorder and organic brain disease compared with negative syndrome structures found in the schizophrenia literature.

Authors:  Matthew S Milak; Dmitry B Aniskin; Daniel P Eisenberg; Alexander Prikhojan; Lisa J Cohen; Samantha S Yard; Igor I Galynker
Journal:  Cogn Behav Neurol       Date:  2007-06       Impact factor: 1.600

8.  Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits.

Authors:  Robert M Roth; Laura A Flashman; Andrew J Saykin; Thomas W McAllister; Robert Vidaver
Journal:  Am J Psychiatry       Date:  2004-01       Impact factor: 18.112

9.  PANSS factors and scores in schizophrenic and bipolar disorders during an index acute episode: a further analysis of the cognitive component.

Authors:  E Daneluzzo; L Arduini; O Rinaldi; M Di Domenico; C Petruzzi; A Kalyvoka; A Rossi
Journal:  Schizophr Res       Date:  2002-07-01       Impact factor: 4.939

Review 10.  Post stroke depression: epidemiology, pathophysiology, and biological treatment.

Authors:  Ellen M Whyte; Benoit H Mulsant
Journal:  Biol Psychiatry       Date:  2002-08-01       Impact factor: 13.382

View more
  4 in total

1.  An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness.

Authors:  Sean M Murphy; Michael G McDonell; Sterling McPherson; Debra Srebnik; Frank Angelo; John M Roll; Richard K Ries
Journal:  Drug Alcohol Depend       Date:  2015-05-14       Impact factor: 4.492

2.  Brain structural signatures of negative symptoms in depression and schizophrenia.

Authors:  Jie-Yu Chuang; Graham K Murray; Antonio Metastasio; Nuria Segarra; Roger Tait; Jenny Spencer; Hisham Ziauddeen; Robert B Dudas; Paul C Fletcher; John Suckling
Journal:  Front Psychiatry       Date:  2014-08-27       Impact factor: 4.157

3.  The Positive and Negative Syndrome Scale (PANSS): A Three-Factor Model of Psychopathology in Marginally Housed Persons with Substance Dependence and Psychiatric Illness.

Authors:  Chantelle J Giesbrecht; Norm O'Rourke; Olga Leonova; Verena Strehlau; Karine Paquet; Fidel Vila-Rodriguez; William J Panenka; G William MacEwan; Geoffrey N Smith; Allen E Thornton; William G Honer
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

Review 4.  Candidate Biomarkers of Suicide Crisis Syndrome: What to Test Next? A Concept Paper.

Authors:  Raffaella Calati; Charles B Nemeroff; Jorge Lopez-Castroman; Lisa J Cohen; Igor Galynker
Journal:  Int J Neuropsychopharmacol       Date:  2020-04-21       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.